Zuckerberg, Bourla among CEOs to attend Trump's state dinner for Xi, sources say: Pfizer CEO Albert Bourla and Meta Platforms chief Mark Zuckerberg are the ...
reuters.com/world/china/pfizer-ceo-bourla-plans-attend-white-house-state-dinner-chinas-xi-source-says-2026-09-22/

Key FactsPfizer Reconsiders Investments Amid Health Policy Shift
Jun 10, 2026 · Reading time: ~45 sec.
Summary created with AI assistance · Source: zeit.de
Summary created with AI assistance · Source: zeit.de
- Pfizer plans to cut investments in Germany due to altered pricing and market conditions.
- CEO Albert Bourla withdrew from the government’s Invest in Germany Summit scheduled for autumn.
- The company criticizes the government’s health policy for undermining investment predictability.
- Eli Lilly and Boehringer Ingelheim have already reduced investments following government austerity measures.
After careful consideration, I regret to inform you that I will not be able to participate on this occasion.— Albert Bourla, CEO of Pfizer, in a letter to German Chancellor Friedrich Merz regarding the Invest in Germany Summit; context: Pfizer is reevaluating investments in Germany amid the government's health policy.
$PFE CEO Albert Bourla shares the latest positive progress on the company's lung cancer drug: DO NOT DELETE - 404 Page

Pfizer CEO Albert Bourla’s best leadership advice: Being optimistic is better than being right
fortune.com/2026/01/31/pfizer-ceo-albert-bourlas-best-leadership-advice-being-optimistic-is-better-than-being-right/

Paid articlePaywall‘We’ll save the world from cancer’: Inside Pfizer CEO’s $23 billion post‑COVID bet on oncology
fortune.com/2026/01/30/pfizer-ceo-save-world-cancer-covid-19-oncology-investment-interview/

Paid articlePaywallAI has the potential to cut trade costs, increase productivity, make advances in healthcare, and enable scientists to go further faster ... Show more
4 takeaways from Davos 2026: New deals, a reckoning, dialogue and questions
4 takeaways from Davos 2026: New deals, a reckoning, dialogue and questions

France rebuffs Trump over drug-pricing boast: Today's biotech news includes: RegenxBio tests FDA consistency under Vinay Prasad, Pfizer CEO's thoughts ...
statnews.com/2026/01/22/biotech-news-2/

Paid articlePaywallPfizer CEO plans for soaring market for obesity drugs: Pfizer is preparing for a consumer market for obesity drugs on par with the booming business it saw after ...
thestar.com.my/business/business-news/2026/01/14/pfizer-ceo-plans-for-soaring-market-for-obesity-drugs

Pfizer CEO vows company will be a ‘formidable competitor’ in booming weight-loss market after $10B buy
foxbusiness.com/media/pfizer-ceo-vows-company-formidable-competitor-booming-weight-loss-market-after-10b-buy

Pfizer CEO Albert Bourla said at CNBC's Invest in America Forum that the company's agreement with the Trump administration to lower drug prices "was the ... Show more
CEOs of Wells Fargo and Pfizer caution the U.S. could lose its edge to China without innovation
cnbc.com/2025/10/15/wells-fargo-pfizer-ceos-china-innovation.html

President announces TrumpRx website for drugs, and pricing deal with Pfizer: The Trump administration says it is making deals with drug companies to lower prices ...
npr.org/sections/shots-health-news/2025/09/30/nx-s1-5558432/drug-prices-trumprx-pfizer

Greek CEO of Pfizer, Albert Bourla, Signs Deal With Trump to Lower Drug Prices - GreekReporter.com
greekreporter.com/2025/10/01/greek-ceo-pfizer-albert-bourla-deal-trump-lower-drug-prices/

OpinionMeet Albert Bourla—Pfizer CEO, Diplomat and Actor: For executives in regulated industries, nothing is more important than pleasing the party in power.
wsj.com/opinion/meet-albert-bourlapfizer-ceo-diplomat-and-actor-cb62515b
Paid articlePaywallNoted germaphobe President Donald Trump was speaking about health matters in the White House when Health and Human Services Secretary Robert F. Kennedy, Jr. ... Show more
Why Pfizer’s TrumpRx Deal Is Good News for Pharma Stocks: The company’s accord with the president clears a cloud over the whole sector
wsj.com/health/pharma/pfizer-trumprx-deal-pharma-stocks-7e2724f4
Paid articlePaywallPfizer CEO Bourla inks deal with POTUS, slams ‘rich’ nations for not sharing in medical innovation#Trump #Pfizer #DrugPrices #TrumpRx #HealthcareReform #Medicaid #MostFavoredNation #AlbertBourla #BigPharma #PrescriptionDrugs ... Show more

Pfizer amps up push into obesity treatments with $4.9B deal for Metsera: Five months after ending development of its own obesity treatment, Pfizer is ...
apnews.com/article/pfizer-metsera-obesity-treatments-e85141f89b670b8d9a7520de3a2fd7c5
Cassidy, Pfizer CEO: Trump worthy of Nobel prize for COVID vaccine: Sen. Bill Cassidy (R-La.) and Pfizer CEO Albert Bourla on Wednesday said President Trump ...
trib.al/cEpIFt9

"Pfizergate": Important text messages from Ursula von der Leyen have been deleted
heise.de/news/Pfizergate-Die-verschwundenen-SMS-der-EU-Kommissionspraesidentin-10509151.html

Key FactsDeleted Texts Obscure Covid Vaccine Negotiations
Aug 4, 2025 · Reading time: ~45 sec.
Summary created with AI assistance · Source: heise.de
Summary created with AI assistance · Source: heise.de
- The EU Commission continues to withhold SMS exchanges between Ursula von der Leyen and Pfizer CEO Albert Bourla during vaccine talks.
- Von der Leyen’s chief of staff decided in 2021 not to archive the messages, considering them mere scheduling notes.
- The texts were deleted after multiple phone replacements and data were not transferred or recoverable.
- The controversy centers on a spring 2021 contract for up to 1.8 billion Covid-19 vaccine doses worth 35 billion euros.
The Commission must provide 'credible explanations that allow the public and the court to understand why these documents are not retrievable'— Judges of the European Court in their ruling from May 2025, addressing the transparency obligations of the EU Commission.
Pfizer CEO attending $25 million fundraiser at Trump's golf club after president demands drug price cuts, sources say
cbsnews.com/news/pfizer-ceo-albert-bourla-trump-golf-club-drug-price-cuts-sources-say/
NYC Mayor Race: Mamdani Talks 'Intifada', Taxes in Grilling by Business Leaders
bloomberg.com/news/articles/2025-07-15/nyc-s-mamdani-talks-intifada-taxes-in-grilling-by-business-leaders

Paid articlePaywallPfizer CEO: HHS claims of ‘concealed safety concerns’ on mRNA vaccines are ‘completely inaccurate’
cnn.com/2025/05/30/health/pfizer-bourla-vaccines

EU court: Von der Leyen must hand over text messages to Pfizer boss: A journalist from the "New York Times" and her newspaper had requested access to all text ...
kleinezeitung.at/hp_ktn/19682528/eu-gericht-genehmigt-antrag-auf-sms-einsicht-von-der-leyens
Key FactsUrsula von der Leyen Loses Court Case Over SMS
May 14, 2025 · Reading time: ~45 sec.
Summary created with AI assistance · Source: welt.de
Summary created with AI assistance · Source: welt.de
- EU Commission President Ursula von der Leyen has lost a court case regarding her text messages to the Pfizer CEO.
- The European Court ruled that the Commission failed to provide a plausible explanation for the absence of the requested documents.
- The case centers around a 2021 vaccine deal between the Commission and Biontech/Pfizer for 1.8 billion doses.
- The Commission must now clarify why the relevant text messages are not available, as doubts about their nonexistence have arisen.
The ruling by the European Court is a landmark victory for transparency in the EU.— Anti-corruption group Transparency International, which hailed the ruling as a significant victory for transparency in the EU.
EU court: Defeat for von der Leyen in lawsuit over text message to Pfizer boss: The EU court upholds a complaint by the “New York Times”. According to the ruling ...
handelsblatt.com/politik/international/eu-gericht-niederlage-fuer-von-der-leyen-im-prozess-um-sms-an-pfizer-chef/100127816.html

Pfizer CEO says tariff uncertainty is deterring further U.S. investment in manufacturing, R&D
cnbc.com/2025/04/29/pfizer-ceo-trump-tariff-uncertainty-is-deterring-us-investment.html

🟡 Tune in to the Healthcare and a Healthy Economy session of the #WorldEconomySummit, featuring @pfizer CEO Dr. Albert Bourla, @reidhoffman, @calleymeans ...
x.com/i/broadcasts/1lDxLzNOXYyGm

Pfizer (PFE) Abandons Obesity Pill After Liver Injury in Major Setback: Pfizer Inc. will stop developing an obesity pill that has been closely watched by ...
bloomberg.com/news/articles/2025-04-14/pfizer-pfe-abandons-obesity-pill-after-liver-injury-in-major-setback

Paid articlePaywallKey FactsPfizer Halts Development of Obesity Pill
Apr 15, 2025 · Reading time: ~30 sec.
Summary created with AI assistance · Source: cnn.com
Summary created with AI assistance · Source: cnn.com
- Pfizer is halting the development of its once-daily obesity pill following a potential drug-induced liver injury in a trial participant.
- The company had intended to advance the medication to late-stage testing but will continue exploring other obesity treatment options.
- Obesity treatments represent a lucrative market, with injectable drugs like Zepbound and Wegovy leading sales.
- Efforts are underway to create an easier-to-take pill, but existing medications face availability issues due to shortages and insurance complications.
Pfizer's CEO says he's got a plan to deal with Trump's tariffs: "I was expecting him probably to win. It was very big win," Pfizer's CEO Albert Bourla said of ...
businessinsider.com/pfizer-ceo-plan-trump-tariffs-move-manufacturing-back-us-2025-3
Pfizer could use existing US manufacturing to counter potential tariff hit: Pfizer CEO Albert Bourla said on Monday the drugmaker might move overseas ...
reuters.com/business/healthcare-pharmaceuticals/pfizer-could-move-outside-manufacturing-us-says-ceo-2025-03-03/

Pfizer's CEO optimistic about working with Trump administration, RFK Jr. : Pfizer CEO Albert Bourla said there are "opportunities that probably outweigh the ...
businessinsider.com/pfizer-ceo-optimistic-about-working-with-trump-administration-rfk-jr-2025-2
Wall Street Week: Concerns About Tariffs and Hope on Cancer: Welcome to the Wall Street Week newsletter, bringing you stories of capitalism about things you need ...
bloomberg.com/news/newsletters/2025-02-08/wall-street-week-concerns-about-tariffs-and-hope-on-cancer

Paid articlePaywallThree major #trends - a rapidly ageing population, growing #urbanization , and the breakneck pace of #technological transformation are set to redefine #healthcare ... Show more
The 3 megatrends that will shape the future of health | World Economic Forum
The 3 megatrends that will shape the future of health | World Economic Forum
Pfizer CEO Is Optimistic Ahead of the Trump Administration: Pfizer CEO Albert Bourla said he had spoken to Robert F. Kennedy Jr. in an effort to “find ...
trib.al/yW9ELsV
Paid articlePaywallPfizer executives descend on Donald Trump’s Mar-a-Lago for planning meeting: Drugmaker is latest titan of corporate America to curry favour with president-elect
ft.com/content/ad6a2867-80e0-4f9b-b59e-8d88c17ffbaa

Von der Leyen’s Commission dodges public responsibility over Pfizergate texts: European Commission lawyer “cannot deny” texts were exchanged, but argued they ...
trib.al/m6NO7Ta

Pfizer Names Oncology Head Boshoff as Chief Science Officer: Pfizer Inc. named oncology research head Chris Boshoff as the drug company’s chief scientific ...
bloomberg.com/news/articles/2024-11-20/pfizer-names-oncology-head-boshoff-as-chief-science-officer

Paid articlePaywallPfizer CEO says turnaround underway as it faces activist pressure: Pfizer CEO Albert Bourla, under pressure from activist hedge fund Starboard Value ...
reuters.com/business/healthcare-pharmaceuticals/pfizer-raises-profit-forecast-after-beating-third-quarter-estimates-2024-10-29/

Pfizer CEO defends performance after Starboard activist criticism: Drugmaker boosts full-year sales and profit forecasts after reporting better than expected ...
ft.com/content/deebf979-5b8c-4ac7-9669-926a063fbca3

Pfizer (PFE) Raises Forecast, Braces for Fight With Starboard: Pfizer Inc. raised its guidance for the year as it reported adjusted earnings that beat ...
bloomberg.com/news/articles/2024-10-29/pfizer-raises-forecast-braces-for-fight-with-starboard

Paid articlePaywallFormer Pfizer executives pull out of activist investor Starboard’s campaign: Hedge fund had enlisted help from ex-chair Ian Read and former finance chief Frank ...
ft.com/content/04e1980e-063c-4068-902c-b870c149884a

Pfizer Went From Covid Star to Activist Target After Stock Drop: Pfizer Inc. and Albert Bourla got the upper hand in an early skirmish against Starboard Value LP ...
trib.al/jaDDrtJ
Pfizer has problems an activist can’t fix: Not quickly, anyway
ft.com/content/0f3e13bd-ba02-47a6-9261-1e49d19d6528

‘Flagrantly unethical’: Pfizer faces $1.5b war: Pfizer is facing a messy showdown this week after an outside bid to revive the company’s post-Covid share plunge ...
news.com.au/finance/business/other-industries/pfizer-faces-showdown-with-15-billion-activist-investor-after-postcovid-share-plunge/news-story/2693775f8d87c0555db0b1489764ea26



